A Possible Role of Therapeutic Drug Monitoring in Virological Breakthrough during Simeprevir and PEG-IFN Treatment in HCV-4

Publisher： Karger

E-ISSN： 1423-0100|59|5-6|283-284

ISSN： 0300-5526

Source： Intervirology, Vol.59, Iss.5-6, 2017-06, pp. : 283-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Prolonged PEG-IFN and RBV Is Effective in Patients with HCV Genotype 1 and High Viral Load Who Achieved Virological Response Later than 24 Weeks

By  

Intervirology, Vol. 53, Iss. 1, 2010-01 ,pp. : 55-59

Karger

Access to resources Recommend Favorite

Usefulness of a New Immunoradiometric Assay of HCV Core Antigen to Predict Virological Response during PEG-IFN/RBV Combination Therapy for Chronic Hepatitis with High Viral Load of Serum HCV RNA Genotype 1b

By  

Intervirology, Vol. 51, Iss. 1, 2008-06 ,pp. : 70-75

Karger

Access to resources Recommend Favorite

Baseline sensitivity of T cells to alpha‐IFN correlates with sustained virological response to IFN‐based triple therapy in HCV infection

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 6, 2015-06 ,pp. : 524-534

John Wiley & Sons Inc

Access to resources Recommend Favorite

Virological and Biochemical Relapse after Discontinuation of Lamivudine Monotherapy for Chronic Hepatitis B in Japan: Comparison with Breakthrough Hepatitis during Long-Term Treatment

By  

Intervirology, Vol. 48, Iss. 2-3, 2005-03 ,pp. : 174-182

Karger

Access to resources Recommend Favorite

Sustained virological response with intravenous silibinin: individualized IFN‐free therapy via real‐time modelling of HCV kinetics

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 2, 2015-02 ,pp. : 289-294

John Wiley & Sons Inc

Access to resources Recommend Favorite